OHSU to expand tumor board program after seeing benefits in breast cancer patients
May 24, 2021
OHSU’s Serial Measurements of Molecular and Architectural Responses to Therapy, or SMMART, program is expanding its multiomics precision cancer management approach to more types of cancer; Gordon Mills, M.D., Ph.D., says: “If you're going to understand what is truly happening, you need to be able to capture what is going on in the tumor pre-therapy, with a deep analysis of DNA, RNA, and protein, and then following therapy.”